Phio Pharmaceuticals Corp (PHIO)

[l2 hunter]

PHIO $9 pop if next days COVID-19 News drop imho

[BEIJING BILL]

110 purcent agreed

[Ownwallstreet]

$PHIO time to break $3.15 and retest those 5's.

[BEIJING BILL]

3.13

[l2 hunter]

PHIO $9 my first goal after next COVID19 News

[BEIJING BILL]

There she goes 3.05

[mick]

$PHIO Phio Pharmaceuticals (PHIO)
2.74 ? 0.11 (4.18%)
Volume: 879,348 @08/07/20 4:00:00 PM EDT
Bid Ask Day's Range
2.72 2.79 2.59 - 2.905
PHIO Detailed Quote

[l2 hunter]

Looks like we finaly going in position for a massiv breakout. COVID-19 PR ahead? $9 my first goal

[BEIJING BILL]

My 2.66 turned into 2.90

Folow the mony.

[BEIJING BILL]

I stil holding here. Lets see 3 plus

[l2 hunter]

Have also load some PHIO. Maybe next huge COVID-19 multiper imho. Game on for me...

[mick]

$PHIO FOLLOWING DA MONEY !!!!!

[alchemytrader]

SFET check chart

[BEIJING BILL]

Im gong to pik up a few here at 2.66

Kwik trede for me perhaps.

[alchemytrader]

Ate small loss on this turd on that pop.

In 2.55 out 2.48/2.47 after it became apparent the volume wasnt strong enough to run through 2.50s.

[The Other Guy]

Only one making any money from this company is Geert Cauwenbergh and Sabby management. In cahoots to rip off the long shareholders. Geert would fabricate and mislead while Sabby shorted the hell out of the stock. I’m sure they still get together for lunch and laugh about the scam.

[the submariner]

This ticker...smh,rxii,mello,Nobel prize...for what????

[alchemytrader]

[The Other Guy]

The company cannot release a morsel of positive news without doing another offer. PHIO won’t go anywhere until the greedy bastards stop diluting.

[alchemytrader]

getting some attention here a/h.

2.50 could pop tomorrow once Robin hood traders catch it.

[VMB-1]

~***Very Low Float***with Updates Looming...

[Ivegotanace2]

Clay do you think PHIO Will go back above $3.00 in June ?

[Ivegotanace2]

PHIO Sure separated to the down side. 3 Red days in a Row :(
Boy would be nice to see green with this one.

[Ivegotanace2]

Definitely a p & D .. They got me for a 65 Cent loss or 20%
Oh well I will put this one on the strong avoid list in the future.

[Ivegotanace2]

Not so much LoL it went below $3 in AH ??? Howcome it opened and traded above $5 and $6 in the 1st hour of trading...
What spooked ppl into driving the PPS Down to $3?

I got in at $3.40 on the Dip so we'll see if we can't get back to $4 next Tues/Wed

[ClayTrader]

* * $PHIO Video Chart 05-29-2020 * *

Link to Video - click here to watch the technical chart video

[UP Trend]

Looks tempting on dip.

[Tomasmith]

Strong / Today Easy 10 - 20+ US$ Amazing

[subslover]

Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity
The new data was presented at the ASCO 2020 Virtual Scientific Program
MARLBOROUGH, Mass., May 29, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced positive data from in vivo studies that show strong antitumoral efficacy with several of its INTASYL pipeline programs, including PH-762, PH-894 and PH-804. These results show that intratumoral delivery of INTASYL compounds inhibited tumor growth by overcoming the immunosuppressive tumor microenvironment (TME) as shown by changes in T cell composition and activation. Therefore, the Company believes these pipeline programs show great promise in the treatment of solid tumors. These data were presented during the ASCO 2020 Virtual Scientific Program (Abstract e15206: "Intratumoral use of self-delivering RNAi to reprogram the tumor microenvironment and boost the antitumor response").

Logo - https://mma.prnewswire.com/media/786567/Phio_Pharmaceuticals_Logo.jpg

The Company's pipeline programs PH-762, PH-894 and PH-804 are INTASYL compounds designed to silence the expression of PD-1, BRD4 and TIGIT, respectively, which are proteins linked to reduced immune cell function in cancer patients. A series of preclinical in vivo studies in tumor models were conducted and the resulting data showed dose-dependent attenuated tumor growth for the INTASYL compounds compared to control groups. Relevant changes in the TME include an increase of tumor-infiltrating lymphocytes, including CD8+ T cells, responsible for tumor cell killing, and an increase of activation markers on these cells. Together, these novel findings support using INTASYL intratumorally as a viable approach to immunotherapy and warrant further investigation in patients.

"These exciting new data show that INTASYL compounds are able to overcome the immunosuppressive TME by reprogramming T cells in order to inhibit tumor growth. These data support our belief that Phio's INTASYL technology can be used to develop powerful immunotherapeutics, which can overcome the shortcomings of currently available systemic immunotherapy," said Dr. Simon Fricker, Phio's VP of Research. "We look forward to continuing our development of INTASYL, including the IND enabling studies which are currently ongoing."

A poster further detailing the data presented at the ASCO 2020 Virtual Scientific Program will be made available under the "Investors – Events and Presentations" section of the Company's website (click here).

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and/or the tumor micro-environment. Our goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities. For additional information, visit the Company's website, www.phiopharma.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future pe

[NGIN]

A company with 5 R/S..yes 5!...should NEVER be listed on NASDAQ...especially when sp is only .000014337 imo

[edwardport]

COULD BE AN OTC STOCK SOON

UNDER $1

[NGIN]

This BIO SCAM sure did imo Thats ALL they do since they were established as RXII!! #SEC #phioFRAUDS

[The Other Guy]

Company screwed investors today. Release positive news and follow up with a direct offering to dilute. Burn those shareholders! WTF!!??

[eebbee]

Could really get going over 3.70 or so.

[Beano1969]

PR Newswire
March 31, 2020, 6:30 am
Animal studies show a complete and statistically significant (p <0.0001) inhibition of tumor growth

MARLBOROUGH, Mass., March 31, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced data from various animal studies validating the potential of Phio's INTASYL technology as a cancer immunotherapy platform for developing novel compounds. The preclinical findings, which will be presented in further detail at upcoming scientific conferences, demonstrate that the INTASYL-enabled compounds can effectively be used to reduce immunosuppression in the tumor microenvironment (TME), which is one of the key challenges for many other immunotherapy platforms to achieve an adequate therapeutic effect in solid tumors.


https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/phio-announces-positive-data-validating-113000532.html

[shurtha2000]

CV play ??

[Liquid1974]

Read yesterday’s news...

[Noseyrosey]

Why is this stock moving today?

[Liquid1974]

Looking for entry

[NGIN]

PHIO is a TOTAL bio PONZI SCAM imo...what bunch for FRAUDS!!! #SEC needs to be investigated for securities fraud and breach of Fiduciary Duties BIGTIME...

[The Other Guy]

6c pre-RS. What a hack job being done by this leadership. Basically just kicked all long term shareholders in the balls. PHIO/RXII is a scam.

[The Other Guy]

The only news PHIO releases is about reverse splits and dilution. Terribly managed since day 1.

[The Other Guy]

Also, it is because of
Nasdaq that these reverse splits occur. Keep in mind, companies only do it to stay Nasdaq compliant. It’s a joke. Especially when Nasdaq does nothing to control the hedge fund shorting that crushes small stocks.

[The Other Guy]

Sadly, a 55/1 reverse split brings such a low float it makes for obvious dilution in the future. PHIO needs money in 2021 or sooner. This company never changes. I have written off any hope of recouping my loses. Geert misguided us about RXII potential. Recall all the interested partners he said of the now-shelved platforms?

[stargazer123]

And I had gone through a couple of them. Sold all that I had left this morning.

[NGIN]

THE BIGGEST bio SCAM the past 20 yrs. #ENRONofBIOS To break even AFTER 5 R/Ss....$47,024.00 PER share...Can't believe NASDAQ allows this to happen after 5 R/Ss...credibility = GONE!

[stargazer123]

Yes, that was a sad disappointment. No press release saying that another company was joining or funding them, which I was holding on to my shares in case they made that announcement instead of an announcement of a reverse split. Ah, well.

EVERY time there is a reverse split, the shares drop and drop, and don't stop dropping, no matter what advances the company has made.

I urge everyone to sell tomorrow. You can wait a little while to see if there is an uptake, but no longer than a few days, or hours, and keep a close eye on the price. If it is dropping, drop the stock.

You can always get back in in the future if there is a breakthrough, or the company starts arranging a joint venture.

Plus you will have the advantage of getting in at lower prices.

[ClayTrader]

* * $PHIO Video Chart 01-14-2020 * *

Link to Video - click here to watch the technical chart video

[proffetti]

1-55 R/S news out today

complete disappointment.

[420man]

Good job......BUT now---> "The Company is taking steps to implement the reverse stock split. The ratio and effective date of the reverse stock split will be reported on a separate Current Report on Form 8-K."